Testing a Light-Based Eye Device to Detect Early Macular Degeneration
Tests a light-imaging device in adults with age-related macular degeneration.
Plain-language title generated from the registry record
Registry title: Direct Discrimination of Quantum States by the Human Eye
Key facts
- Where
- Hong Kong, Hong KongSee the site
Where in Hong Kong
- Centre for Eye and Vision Research LimitedHong Kong, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre for Eye and Vision Research
- Trial code
- NCT05913063
- Record updated
- 18 March 2026
- Original description
Age-related macular degeneration (AMD), is a debilitating eye disease that causes a loss of central vision. The prevalence of AMD increases exponentially with age and causes a significant impact through both medical expenses and the social and economic costs associated with vision loss. AMD is the global leading cause of blindness among people over the age of 60. Detection of this eye disease at early stages coupled with prompt treatment can prevent vision loss; however, modern diagnosis methods are ineffective at diagnosis of AMD before vision loss occurs. While a range of available treatment options has been effective at slowing vision loss due to AMD, no treatment exists which can recover lost vision. The investigators propose to apply tools developed in quantum information science to diagnose AMD before vision has been affected, drastically improving health outcomes for patients with AMD.Read full original descriptionShow less
Direct Discrimination of Quantum States by the Human Eye With Macular Degeneration
Age-related macular degeneration (AMD), is a debilitating eye disease that causes a loss of central vision. The prevalence of AMD increases exponentially with age and causes a significant impact through both medical expenses and the social and economic costs associated with vision loss. AMD is the global leading cause of blindness among people over the age of 60. Detection of this eye disease at early stages coupled with prompt treatment can prevent vision loss; however, modern diagnosis methods are ineffective at diagnosis of AMD before vision loss occurs. While a range of available treatment options has been effective at slowing vision loss due to AMD, no treatment exists which can recover lost vision. The investigators propose to apply tools developed in quantum information science to diagnose AMD before vision has been affected, drastically improving health outcomes for patients with AMD.
Inclusion: Participants who are clinically diagnosed with a vision disease affecting their macula; Older adults who are matched for age; Participants who are clinically diagnosed with glaucoma; Participants who have normal vision; One aged-matched control with normal vision will be recruited for each of the diagnosed groups (born in the same year).
Exclusion: Participants with any additional eye diagnosis or condition.